Jaguar Health, Inc. (JAGX) delivered a return of -97.43% over the past year. Since JAGX does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Jaguar Health, Inc. one year ago would be worth $257 today, representing a loss of $9,743.

Jaguar Health, Inc. (JAGX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For JAGX, the total return equals the price-only return.

No, Jaguar Health, Inc. (JAGX) underperformed the S&P 500 by 118.27 percentage points over the past year. JAGX delivered a total return of -97.43%, compared to the S&P 500's 20.84%. This means a passive S&P 500 index fund outperformed JAGX by 118.27pp during this period.

Jaguar Health, Inc. (JAGX) experienced a maximum drawdown of -99.19% over the past year, declining from its peak on 2025-06-24 to its trough on 2026-01-24. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are Jaguar Health, Inc. (JAGX)'s long-term returns with dividends reinvested. Over 10 years, the total return is -100.0% (-72.0% CAGR) — $10,000 would have grown to $0. Over 20 years: -100.0% total return (-47.1% CAGR) — $10,000 → $0. Over 30 years: -100.0% total return (-34.6% CAGR) — $10,000 → $0. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Jaguar Health, Inc.'s best calendar year was 2020 with a total return of 3.5%. Its worst year was 2023 with a total return of -97.7%. This range shows the volatility investors should expect — the difference between the best and worst year is 101.2 percentage points.